SLC18A2 and Tremor: Common TEAEs observed in our study such as somnolence, tremor, and hypersalivation are thought to be caused by the pharmacological effects of VMAT2 inhibitors (i.e., a decrease in monoamine transporter activity), and the incidence of such events might be expected to increase with increased valbenazine exposure.